Defining cognitive and functional profiles in schizophrenia and affective disorders
- PMID: 32005199
- PMCID: PMC6995055
- DOI: 10.1186/s12888-020-2459-y
Defining cognitive and functional profiles in schizophrenia and affective disorders
Abstract
Background: Neurocognitive dysfunction is a common symptom of various major psychiatric disorders, including schizophrenia, major depressive disorder (MDD), and bipolar I disorder (BD). In this study, we investigated whether cognitive profiles and daily skill functioning could effectively differentiate between patients with schizophrenia, MDD, and BD.
Method: In this cross-sectional study, we recruited a total of 63 patients with schizophrenia, 55 patients with MDD, 43 patients with BD, and 92 healthy control subjects. We evaluated participants' cognitive functions and functional capacity using the Brief Assessment of Cognition in Schizophrenia (BACS) and the UCSD Performance-based Skills Assessment, Brief Version (UPSA-B), respectively. Multivariate analysis of covariance was then adopted to determine inter-group differences in BACS and UPSA-B performance.
Results: The BACS was capable of differentiating patients with a major psychiatric disorder (schizophrenia, MDD, and BD) from healthy subjects. Furthermore, schizophrenia patients had poorer motor speed performance than patients with affective disorders. The UPSA-B, particularly the financial portion, was able to distinguish schizophrenia patients from other groups. However, we did not observe any differences in UPSA-B performance between patients with mood disorders and the healthy controls. No significant difference between patients with BD and those with MDD were observed in either cognitive function or in functional capacity. The performances of the BACS and the UPSA-B were positively correlated, particularly in the MDD group.
Conclusion: Considering overall performance, the BACS and the UPSA-B characterize different endophenotyping profiles in the aforementioned four participant groups. Therefore, the results support the need for comprehensive assessments that target both cognitive function and functional capacity for patients with major psychiatric disorders.
Keywords: Daily skill functioning; Depression; Mania; Neurocognitive tests; Schizophrenia.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures


Similar articles
-
Comparison of neurocognitive function in major depressive disorder, bipolar disorder, and schizophrenia in later life: A cross-sectional study of euthymic or remitted, non-demented patients using the Japanese version of the Brief Assessment of Cognition in Schizophrenia (BACS-J).Psychiatry Res. 2017 Aug;254:205-210. doi: 10.1016/j.psychres.2017.04.058. Epub 2017 Apr 28. Psychiatry Res. 2017. PMID: 28476012
-
Could schizoaffective disorder, schizophrenia and bipolar I disorder be distinguishable using cognitive profiles?Psychiatry Res. 2018 Aug;266:79-84. doi: 10.1016/j.psychres.2018.05.062. Epub 2018 May 24. Psychiatry Res. 2018. PMID: 29852325
-
Relationship of the Brief UCSD Performance-based Skills Assessment (UPSA-B) to multiple indicators of functioning in people with schizophrenia and bipolar disorder.Bipolar Disord. 2010 Feb;12(1):45-55. doi: 10.1111/j.1399-5618.2009.00787.x. Bipolar Disord. 2010. PMID: 20148866 Free PMC article.
-
Cognitive deficits in bipolar disorders: Implications for emotion.Clin Psychol Rev. 2018 Feb;59:126-136. doi: 10.1016/j.cpr.2017.11.006. Epub 2017 Nov 21. Clin Psychol Rev. 2018. PMID: 29195773 Free PMC article. Review.
-
Targeting hypothalamic-pituitary-adrenal axis hormones and sex steroids for improving cognition in major mood disorders and schizophrenia: a systematic review and narrative synthesis.Psychoneuroendocrinology. 2018 Jul;93:8-19. doi: 10.1016/j.psyneuen.2018.04.012. Epub 2018 Apr 14. Psychoneuroendocrinology. 2018. PMID: 29680774
Cited by
-
Validation of the Chinese Version of the Schizophrenia Cognition Rating Scale.Psychiatry Investig. 2022 Jul;19(7):511-518. doi: 10.30773/pi.2021.0322. Epub 2022 Jul 21. Psychiatry Investig. 2022. PMID: 35903053 Free PMC article.
-
Comparison of cognitive performance in first-episode drug-naïve schizophrenia, bipolar II disorder, and major depressive disorder patients after treatment.BMC Psychiatry. 2024 Jun 11;24(1):434. doi: 10.1186/s12888-024-05897-8. BMC Psychiatry. 2024. PMID: 38862969 Free PMC article.
-
An examination of neurocognition and theory of mind as predictors of engagement with a tailored digital therapeutic in persons with serious mental illness.Schizophr Res Cogn. 2022 Jan 17;28:100236. doi: 10.1016/j.scog.2022.100236. eCollection 2022 Jun. Schizophr Res Cogn. 2022. PMID: 35242605 Free PMC article.
-
Methods to Identify Cognitive Alterations from Animals to Humans: A Translational Approach.Int J Mol Sci. 2023 Apr 21;24(8):7653. doi: 10.3390/ijms24087653. Int J Mol Sci. 2023. PMID: 37108813 Free PMC article. Review.
-
Graph Analysis of Verbal Fluency Tests in Schizophrenia and Bipolar Disorder.Brain Sci. 2022 Jan 27;12(2):166. doi: 10.3390/brainsci12020166. Brain Sci. 2022. PMID: 35203930 Free PMC article.
References
-
- Bourne C, Aydemir O, Balanza-Martinez V, Bora E, Brissos S, Cavanagh JT, Clark L, Cubukcuoglu Z, Dias VV, Dittmann S, et al. Neuropsychological testing of cognitive impairment in euthymic bipolar disorder: an individual patient data meta-analysis. Acta Psychiatr Scand. 2013;128(3):149–162. doi: 10.1111/acps.12133. - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical